<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Royal (Dick) School of Veterinary Scienc</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1C2EEA30-8EDC-4335-B896-240E712D2D9C"><gtr:id>1C2EEA30-8EDC-4335-B896-240E712D2D9C</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Mabbott</gtr:surname><gtr:orcidId>0000-0001-7395-1796</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FG003947%2F1"><gtr:id>EA941136-117A-4A35-8874-B4CA28FD1402</gtr:id><gtr:title>The influence of the GALT in TSE agent neuroinvasion from the large intestine</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/G003947/1</gtr:grantReference><gtr:abstractText>Transmissible spongiform encephalophathies (TSEs) are prolonged diseases which cause extensive damage to nerves in the brain. In the absence of a cure TSE diseases are invariably fatal. These diseases affect both animals and humans, and include Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy in cattle, chronic wasting disease in mule deer and elk, and scrapie in sheep and goats. Some animal species and humans have become infected with these diseases after eating TSE agent-contaminated food, or through transplantation of TSE agent-contaminated tissues or tissue products (eg: transfusion of blood from a variant CJD-infected donor). Many questions remain concerning the route the infectious TSE agent takes from the site of exposure (eg: intestine) to the brain where it causes damage to nerve cells. We have shown that soon after exposure TSE agents first target and accumulate within lymphoid tissues (Peyer's patches in the small intestine, lymph nodes and spleen) before they spread to the brain. Many TSE agents must accumulate in these lymphoid tissues before they can subsequently spread to the brain (a process termed neuroinvasion) where they ultimately cause neurodegeneration and death. After oral exposure TSE agents also accumulate within lymphoid tissues in the large intestine such as the appendix. However, the contribution of the large intestine to oral TSE pathogenesis is unknown and has been mostly overlooked. This is unfortunate as the large intestine may be an important early site of TSE agent accumulation that influences disease susceptibility. For example, inflammation or pathology within the large intestine may affect disease susceptibility. In the current project, mice will be created that contain lymphoid tissues in the large intestine only. These mice will be used to test the hypothesis that lymphoid tissues in the large intestine are important sites of TSE agent accumulation which influence disease pathogenesis and susceptibility. To achieve this, the following measurable objectives will be addressed: Objective 1- Characterise the development and status of the lymphoid tissues within the small and large intestines Objective 2- Determine the influence of lymphoid tissues in TSE agent neuroinvasion from the large intestine Finally, the effects that other intestinal pathogens may have on TSE susceptibility are not known. For example, the pathology that these pathogens cause in the intestine may increase the uptake of the TSE agent, whereas an influx of inflammatory cells may destroy the TSE agent reducing susceptibility. In Objective 3 the effects of infection with a common gut parasite on oral TSE pathogenesis will be determined. These data will provide predictions on how infection with gastrointestinal pathogens may influence TSE susceptibility. Objective 3- Determine the influence of infection with a gastrointestinal pathogen on oral TSE pathogenesis Currently, effective therapeutics and prophylactics to treat TSE diseases are lacking. Furthermore, no reliable preclinical diagnostic test is available. A thorough understanding of the early events in TSE pathogenesis will aid the determination of risk, the development of pre-clinical diagnostics and therapeutics, especially the development TSE-specific mucosal vaccines.</gtr:abstractText><gtr:technicalSummary>After oral exposure transmissible spongiform encephalopathy (TSE) agent accumulation in the gut-associated lymphoid tissues (GALT), especially Peyer's patches and isolated lymphoid follicles in the small intestine, is critical for the spread of disease to the brain. Many TSE agents also accumulate within GALT in the large intestine such as the appendix and rectal-associated lymphoid follicles, but the influence this has on pathogenesis is unknown. The large intestine GALT may be important early sites of TSE agent accumulation that influence disease susceptibility. Here, mice will be created that contain large intestine GALT only. Transient in utero lymphotoxin-blockade blocks Peyer's patch, colonic patch and lymph node formation, but stimulates the post-natal development of isolated lymphoid follicles throughout the intestine. Interestingly, large intestine isolated lymphoid follicles develop several weeks before those in the small intestine. These characteristics will be used to create mice that contain large intestine GALT only (large intestine-isolated lymphoid follicles) at the time of oral TSE agent exposure. These mice will be used to test the hypothesis that the large intestine GALT is also an important site of TSE agent accumulation and neuroinvasion. To do so, the following objectives will be addressed: Objective 1- Characterise the development and status of the GALT in the small and large intestines during the first few weeks of development Objective 2- Determine the influence of the GALT in TSE agent neuroinvasion from the large intestine Objective 3- Determine the influence of infection with a gastrointestinal pathogen on oral TSE pathogenesis This experiment will provide predictions on how infection with other gut pathogens may affect TSE pathogenesis. A thorough understanding of the early events in TSE pathogenesis will aid the determination of risk, the development of pre-clinical diagnostics and therapeutics, especially mucosal vaccines.</gtr:technicalSummary><gtr:fund><gtr:end>2012-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-05-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>350321</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Brain infection study reveals how disease spreads from gut</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EE37A989-01E1-4BD4-8F55-7E0C1106CB1D</gtr:id><gtr:impact>Press release describing our study published in the Journal of Virology: http://jvi.asm.org/content/89/18/9532.long</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.ed.ac.uk/news/2015/prions-040815</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keeping bugs at Bay: a Public Engagement Activity at the Roslin Institute 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7E6627B4-CF6A-4C85-B7FB-E89BB774EF90</gtr:id><gtr:impact>This activity aims to teach people how the immune system fights bugs.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keeping bugs at Bay: a Public Engagement Activity at the Royal Highland Show 2015</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2ADD130-740B-435A-A022-87346CB1FDAB</gtr:id><gtr:impact>This activity aims to teach people how the immune system fights bugs.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>Mexico, United Mexican States</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Council on Science and Technology (CONACYT)</gtr:department><gtr:description>Study of effects of helminth infection on prion disease pathogenesis</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Government of Mexico</gtr:fundingOrg><gtr:id>E94E7F67-D08B-4CD1-8F03-4825EBA0BEF6</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>-Demonstrated for the first time that distinct mechanisms regulate the development of the GALT in the large and small intestines. 

-Demonstrated for the first time that the large intestine is not a primary site of TSE agent neuroinvasion after oral exposure.

-Demonstrated for the first time that congruent parasite infection in the large intestine does not influence oral TSE pathogenesis or susceptibility.

-Demonstrated for the first time that a congruent parasite infection in the large intestine can exacerbate the onset of clinical TSE disease.</gtr:description><gtr:exploitationPathways>Our data demonstrate that the GALT in the small intestine, not the large intestine, are the major early sites of prion accumulation and neuroinvasion after oral exposure. This has important implications for our understanding of the factors that influence the risk to infection and the pre-clinical diagnosis of disease. Although large intestine GALT are not early sites of infection, the detection of PrPSc within the RAMALT and appendix has proved to be a useful method to detect prion-infected individuals during the pre-clinical phase, and has been used in the United Kingdom to gain insight into the possible prevalence of vCJD in the human population. However, our data suggest that the time at which these tissues are sampled in relation to prion exposure may dramatically affect the sensitivity of these assays. For instance, humans with subclinical vCJD infection may only have minimal PrP deposition in appendiceal tissue. Our data show that analyses of such biopsies may miss individuals in the early stages of oral prion infection and underestimate the disease prevalence.</gtr:exploitationPathways><gtr:id>6C60E547-345B-4E7A-86C6-2695AE53D886</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors><gtr:url>http://jvi.asm.org/cgi/pmidlookup?view=long&amp;pmid=26157121</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2BFBF2BD-0486-4B3E-B83A-9CD9C1465035"><gtr:id>2BFBF2BD-0486-4B3E-B83A-9CD9C1465035</gtr:id><gtr:title>Evidence of subclinical prion disease in aged mice following exposure to bovine spongiform encephalopathy.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/700fbb235965330040dfaa9897517a46"><gtr:id>700fbb235965330040dfaa9897517a46</gtr:id><gtr:otherNames>Brown KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A0B1683-A531-451F-9FAC-931EE4648B2D"><gtr:id>3A0B1683-A531-451F-9FAC-931EE4648B2D</gtr:id><gtr:title>Identification of novel genes selectively expressed in the follicle-associated epithelium from the meta-analysis of transcriptomics data from multiple mouse cell and tissue populations.</gtr:title><gtr:parentPublicationTitle>DNA research : an international journal for rapid publication of reports on genes and genomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33342a95a5440ee213f0804af9129157"><gtr:id>33342a95a5440ee213f0804af9129157</gtr:id><gtr:otherNames>Kobayashi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1340-2838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FE4C55D-4CE0-4DA1-8950-F9AF34E41BAA"><gtr:id>6FE4C55D-4CE0-4DA1-8950-F9AF34E41BAA</gtr:id><gtr:title>The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4ae76722b706ebf7ff076cff357a4c5"><gtr:id>c4ae76722b706ebf7ff076cff357a4c5</gtr:id><gtr:otherNames>Donaldson DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/133C5672-7072-4E36-A2DA-C33DA2ED0948"><gtr:id>133C5672-7072-4E36-A2DA-C33DA2ED0948</gtr:id><gtr:title>Human prion diseases and the risk of their transmission during anatomical dissection.</gtr:title><gtr:parentPublicationTitle>Clinical anatomy (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0897-3806</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15682A72-05DD-45F6-B6BE-DFDBBE484B84"><gtr:id>15682A72-05DD-45F6-B6BE-DFDBBE484B84</gtr:id><gtr:title>Reciprocal regulation of lymphoid tissue development in the large intestine by IL-25 and IL-23.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4ae76722b706ebf7ff076cff357a4c5"><gtr:id>c4ae76722b706ebf7ff076cff357a4c5</gtr:id><gtr:otherNames>Donaldson DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/622A1EF5-7B03-41E7-BD0F-1FEC04AB945D"><gtr:id>622A1EF5-7B03-41E7-BD0F-1FEC04AB945D</gtr:id><gtr:title>Prion uptake in the gut: identification of the first uptake and replication sites.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dc712debcc9f619fdfa52f736c1722dd"><gtr:id>dc712debcc9f619fdfa52f736c1722dd</gtr:id><gtr:otherNames>Kujala P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B6B315E7-477A-497C-AC8F-4392605E49E3"><gtr:id>B6B315E7-477A-497C-AC8F-4392605E49E3</gtr:id><gtr:title>Determining the influence of the host immune system on TSE pathogenesis</gtr:title><gtr:parentPublicationTitle>EBRC Launch</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b32c6588e86101875805ed943e120df"><gtr:id>7b32c6588e86101875805ed943e120df</gtr:id><gtr:otherNames>MAbbott, N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DEC66A40-DE3C-4B6B-931C-FAB3234E11C4"><gtr:id>DEC66A40-DE3C-4B6B-931C-FAB3234E11C4</gtr:id><gtr:title>The influence of the commensal and pathogenic gut microbiota on prion disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4ae76722b706ebf7ff076cff357a4c5"><gtr:id>c4ae76722b706ebf7ff076cff357a4c5</gtr:id><gtr:otherNames>Donaldson DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A4E3B94C-4024-4706-94C4-5E6984E6B421"><gtr:id>A4E3B94C-4024-4706-94C4-5E6984E6B421</gtr:id><gtr:title>M cell-depletion blocks oral prion disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4ae76722b706ebf7ff076cff357a4c5"><gtr:id>c4ae76722b706ebf7ff076cff357a4c5</gtr:id><gtr:otherNames>Donaldson DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB6C3A62-C5D4-44F1-BE49-9A329A7D1E6B"><gtr:id>EB6C3A62-C5D4-44F1-BE49-9A329A7D1E6B</gtr:id><gtr:title>Differential regulation of small intestinal and colonic lymphoid tissue development by IL-23 and regulatory T cells</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9def85d83c53959d203d6aa12a2eb531"><gtr:id>9def85d83c53959d203d6aa12a2eb531</gtr:id><gtr:otherNames>Donaldson, D.S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CCDB3FA9-E289-4421-931F-CD770B0BAF75"><gtr:id>CCDB3FA9-E289-4421-931F-CD770B0BAF75</gtr:id><gtr:title>M cell-depletion blocks oral prion pathogenesis</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9def85d83c53959d203d6aa12a2eb531"><gtr:id>9def85d83c53959d203d6aa12a2eb531</gtr:id><gtr:otherNames>Donaldson, D.S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D818AE9E-FCF4-4E04-94C4-3E9219517478"><gtr:id>D818AE9E-FCF4-4E04-94C4-3E9219517478</gtr:id><gtr:title>The functional maturation of M cells is dramatically reduced in the Peyer's patches of aged mice.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33342a95a5440ee213f0804af9129157"><gtr:id>33342a95a5440ee213f0804af9129157</gtr:id><gtr:otherNames>Kobayashi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0983705-6A95-49A4-B8DA-669DD00EC7AD"><gtr:id>E0983705-6A95-49A4-B8DA-669DD00EC7AD</gtr:id><gtr:title>The development of isolated lymphoid follicles in the large intestine</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9def85d83c53959d203d6aa12a2eb531"><gtr:id>9def85d83c53959d203d6aa12a2eb531</gtr:id><gtr:otherNames>Donaldson, D.S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/60029A75-FC7A-4A71-8A85-D12708B36E1E"><gtr:id>60029A75-FC7A-4A71-8A85-D12708B36E1E</gtr:id><gtr:title>Regulation of colonic isolated lymphoid follicle development by IL-25 and IL-23</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a505fb7f8df02670803f89723e04ceba"><gtr:id>a505fb7f8df02670803f89723e04ceba</gtr:id><gtr:otherNames>Donaldson D.S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/851403C7-2C13-4310-AC5E-A8F3744DD9B6"><gtr:id>851403C7-2C13-4310-AC5E-A8F3744DD9B6</gtr:id><gtr:title>The Good, the Bad, and the Ugly of Dendritic Cells during Prion Disease.</gtr:title><gtr:parentPublicationTitle>Journal of immunology research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2314-7156</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68023F8C-D682-4508-A220-F92F004334DE"><gtr:id>68023F8C-D682-4508-A220-F92F004334DE</gtr:id><gtr:title>From Scientific Curiosity to Public Enemy Number One in Six Short Months.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA5D60BE-69B8-4342-BCA0-66C28996FD74"><gtr:id>CA5D60BE-69B8-4342-BCA0-66C28996FD74</gtr:id><gtr:title>Prion pathogenesis and secondary lymphoid organs (SLO): tracking the SLO spread of prions to the brain.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A73DFAF-1306-40A2-BA38-5BA0007D9EAB"><gtr:id>9A73DFAF-1306-40A2-BA38-5BA0007D9EAB</gtr:id><gtr:title>Prospects for safe and effective vaccines against prion diseases.</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/217E2DDE-094A-4E72-BE31-DB167077B89B"><gtr:id>217E2DDE-094A-4E72-BE31-DB167077B89B</gtr:id><gtr:title>Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67ED53E3-9EFE-49C5-A500-C22D213162C4"><gtr:id>67ED53E3-9EFE-49C5-A500-C22D213162C4</gtr:id><gtr:title>Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/134a5b8a0651a7cb0272cbec28d7b551"><gtr:id>134a5b8a0651a7cb0272cbec28d7b551</gtr:id><gtr:otherNames>Tahoun A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G003947/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>